Dr. William Stauffer

MD, MSPH, FASTMH

Honorary Conference Chair

Dr. William Stauffer, MD MSPH FASTMH is formally trained in public health, internal medicine, pediatrics, emergency medicine and infectious diseases.

Dr. William Stauffer, MD MSPH FASTMH

About Dr. William Stauffer

Team Member

Dr. William Stauffer is currently on LOA from the University of Minnesota and is a Professor of Medicine and Executive Field Director of AMPATH-Kenya, and Stephanie and Craig Brater Professor at the Indiana University of Center for Global Health, Division of Infectious Diseases, Department of Medicine.

Dr. Stauffer has been a Professor in the Departments of Medicine and Pediatrics, Division of Infectious Disease and International Medicine, at the University of Minnesota where he is the Director of Human Migration and Health at the Center for Global Health and Social Responsibility in the School of Public Health.

A Guest Researcher with CDC, he served as the Lead Medical Advisor for the Immigrant, Refugee Migrant Health Branch in DGMH from 2005-2019, where he spearheaded refugee health guidance and worked on other issues involved in human mobility and health.

He is also co-PI of the National Resource Center for Refugees, Immigrants and Migrants (NRC-RIM).  NRC-RIM was a lead public health response to COVID in the US in RIM populations and, more recently, for responding to the Afghan and Ukrainian refugee situation. 

He founded the UMN Global Medicine Program and UMN/CDC Global Health Course. He has worked extensively overseas in clinical medicine education, research and in public health in more than a dozen countries in Africa, Asia and the Middle east.  He works extensively with IOM/United Nations Migration Agency/IOM and founded and works on the IOM-University of Minnesota Collaborative.

He has also acted/acts as an advisor to the European Centers for Disease Control, the World Health Organization. His research areas have included refugee and immigrant health issues, infectious disease surveillance, diagnostics, neglected tropical diseases, evaluations of public health programs, and examining drug costs and impact on patient.

Learn more about us and our team